Proteinase-3 directly activates MMP-2 and degrades gelatin and matrigel;: differential inhibition by (-)epigallocatechin-3-gallate

被引:33
|
作者
Pezzato, E
Donà, M
Sartor, L
Dell'Aica, I
Benelli, R
Albini, A
Garbisa, S
机构
[1] Univ Padua, Sch Med, Dept Expt Biomed Sci, I-35121 Padua, Italy
[2] Natl Inst Canc Res, IST, Mol Biol Lab, Genoa, Italy
关键词
neutrophils; gelatinolysis; EGCG;
D O I
10.1189/jlb.0203086
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Proteinase-3 (PR-3), a serine-proteinase mainly expressed by polymorphonuclear leukocytes (PMNs), can degrade a variety of extracellular matrix proteins and may contribute to a number of inflammation-triggered diseases. Here, we show that in addition to Matrigel(TM) components, PR-3 is also able to degrade denatured collagen and directly activate secreted but not membrane-bound pro-MMP-2, a matrix metallo-proteinase instrumental to cellular invasion. In contrast, following addition of purified PR-3 or PMNs to HT1080 tumor cells, dose-dependent inhibition. of in vitro Matrigel(TM) invasion is registered. (-)Epigallocatechin-3-gallate (EGCG), the main flavanol in green tea and known to inhibit inflammation and tumor invasion, exerts dose-dependent inhibition of degradation of gelatin (IC50<20 muM) and casein, which is directly triggered by PR-3. The presence of EGCG does not modify the colocalization of MMP-2 and exogenous PR-3 at the cell surface and does not restrain secreted pro-MMP-2 and proMMP-9 activation or degradation of a specific, synthetic peptide by PR-3. These results add new activities to the list of those exerted by PR-3 and indicate a differential inhibition as a result of EGCG.
引用
收藏
页码:88 / 94
页数:7
相关论文
共 50 条
  • [41] Proteasome inhibition and induction of cell death by EGCG [(-)-Epigallocatechin-3-gallate] in chronic lymphocytic leukaemia
    Ponath, E.
    Schnabl, S.
    Hilgarth, M.
    Demirtas, D.
    Reiter, M.
    Hubmann, R.
    Zielinski, C.
    Jaeger, U.
    Shehata, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 240 - 240
  • [42] EPIGALLOCATECHIN-3-GALLATE PROTECTS KIDNEYS FROM ISCHEMIA REPERFUSION INJURY BY INHIBITION OF MACROPHAGE INFILTRATION
    Kakuta, Yoichi
    Okumi, Masayoshi
    Tsutahara, Koichi
    Abe, Toyofumi
    Yazawa, Koji
    Matsumura, Kazuaki
    Hyon, Suong-Hyu
    Takahara, Shiro
    Nonomura, Norio
    JOURNAL OF UROLOGY, 2011, 185 (04): : E902 - E902
  • [43] Inhibition of liver cancer cell proliferation and migration by a combination of (-)-epigallocatechin-3-gallate and ascorbic acid
    Wei, DZ
    Yang, JY
    Liu, JW
    Tong, WY
    JOURNAL OF CHEMOTHERAPY, 2003, 15 (06) : 591 - 595
  • [44] Antidiabetic activity of lipophilic (-)-epigallocatechin-3-gallate derivative under its role of α-glucosidase inhibition
    Li, Ting
    Liu, Jianwen
    Zhang, Xiaodong
    Ji, Guang
    BIOMEDICINE & PHARMACOTHERAPY, 2007, 61 (01) : 91 - 96
  • [45] Epigallocatechin-3-Gallate Attenuates Myocardial Dysfunction via Inhibition of Endothelial-to-Mesenchymal Transition
    Kim, Sejin
    Lee, Hyunjae
    Moon, Hanbyeol
    Kim, Ran
    Kim, Minsuk
    Jeong, Seongtae
    Kim, Hojin
    Kim, Sang Hyeon
    Hwang, Soo Seok
    Lee, Min Young
    Kim, Jongmin
    Song, Byeong-Wook
    Chang, Woochul
    ANTIOXIDANTS, 2023, 12 (05)
  • [46] Inhibition of intestinal tumorigenesis in Apcmin/+ mice by (-)-epigallocatechin-3-gallate, the major catechin in green tea
    Ju, J
    Hong, J
    Zhou, JN
    Pan, Z
    Bose, M
    Liao, J
    Yang, GY
    Lin, YY
    Hou, Z
    Lin, Y
    Ma, JJ
    Shih, WJ
    Carothers, AM
    Yang, CS
    CANCER RESEARCH, 2005, 65 (22) : 10623 - 10631
  • [47] Inhibition of Al(III)-Induced Aβ42 Fibrillation and Reduction of Neurotoxicity by Epigallocatechin-3-Gallate Nanoparticles
    Singh, Neha Atulkumar
    Mandal, Abul Kalam Azad
    Khan, Zaved Ahmed
    JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2018, 14 (06) : 1147 - 1158
  • [48] Inhibition of eleven mutagens by various tea extracts, (-)epigallocatechin-3-gallate, gallic acid and caffeine
    Hour, TC
    Liang, YC
    Chu, IS
    Lin, JK
    FOOD AND CHEMICAL TOXICOLOGY, 1999, 37 (06) : 569 - 579
  • [49] EGFR inhibition by (-)-epigallocatechin-3-gallate and IIF treatments reduces breast cancer cell invasion
    Farabegoli, Fulvia
    Govoni, Marzia
    Spisni, Enzo
    Papi, Alessio
    BIOSCIENCE REPORTS, 2017, 37
  • [50] Differential expression of survivin splice variants during testicular torsion and their modulation by (-)-epigallocatechin-3-gallate
    Al-Maghrebi, M.
    Renno, W. M.
    Al-Ajmi, N.
    FEBS JOURNAL, 2013, 280 : 237 - 238